Benoquin 40 Cream (Monobenzone) – Vitiligo Depigmentation Treatment
Buy Benoquin 40 Cream from Tabexports – Global Pharmaceutical Exporter
Benoquin 40 Cream (Monobenzone 40%) is a dermatological medication used for permanent depigmentation therapy in patients with extensive vitiligo. The active ingredient Monobenzone works by reducing melanin production in the skin, helping to achieve a more uniform skin tone where vitiligo has caused uneven pigmentation.
Tabexports supplies Benoquin 40 Cream for international pharmaceutical markets, offering bulk export, wholesale supply, and reliable global delivery to United States, United Kingdom, Australia, France, Thailand, and worldwide healthcare distributors.
Active Ingredient
-
Monobenzone 40%
Monobenzone acts as a skin depigmenting agent, gradually destroying melanocytes responsible for melanin production, resulting in permanent lightening of pigmented skin areas.
Medical Uses
✔ Treatment of extensive vitiligo
✔ Permanent skin depigmentation therapy
✔ Helps create uniform skin color in severe vitiligo
✔ Dermatological treatment for pigment disorders
⚠ This medicine should be used only under dermatologist supervision.
Key Benefits
-
Effective depigmentation therapy for vitiligo
-
Helps achieve even skin tone
-
Widely prescribed in dermatology treatments
-
High-strength 40% Monobenzone formulation
-
Reliable treatment for severe pigmentation imbalance
Directions for Use
-
Clean and dry the affected area before application.
-
Apply a thin layer of Benoquin 40 Cream to pigmented skin areas.
-
Use once or twice daily or as directed by a healthcare professional.
-
Avoid excessive sun exposure during treatment.
Storage Instructions
-
Store below 25°C
-
Keep away from direct sunlight
-
Keep out of reach of children
Why Choose Tabexports?
🌍 Worldwide pharmaceutical exporter
📦 Bulk supply for wholesalers and distributors
🚚 Reliable international shipping
🏭 Quality-assured pharmaceutical sourcing
📈 Trusted global medicine supplier
Tabexports exports Benoquin 40 Cream (Monobenzone) to USA, UK, Australia, France, Thailand, and worldwide pharmaceutical markets.





Reviews
There are no reviews yet.